Search
for
Sort by
Research 841–870 of 1000+
- Unraveling the Molecular Mechanisms of Hair and Nail Genodermatoses
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Pediatric Psychocutaneous Disorders
- THALLIUM POISONING
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- The pathophysiology of delayed ejaculation
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Scleroderma and L-tryptophan: A possible explanation of the eosinophilia-myalgia syndrome
- An Update on Drug-Induced Pigmentation
- Secondary cicatricial and other permanent alopecias
- Cutaneous manifestations of metabolic diseases: uncommon presentations
- Immediate and Delayed Complications of Dexamethasone Cyclophosphamide Pulse (DCP) Therapy
- ADVANCES IN PSORIASIS THERAPY
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Topical use of systemic drugs in dermatology: A comprehensive review
- COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
- Phenolsulphotransferase: localization in kidney during human embryonic and fetal development
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- PROTECTION AGAINST CYTOSINE ARABINOSIDE-INDUCED ALOPECIA BY MINOXIDIL IN A RAT ANIMAL MODEL
- Minoxidil: a comprehensive review
- Selenium and Polycystic Ovary Syndrome; Current Knowledge and Future Directions: A Systematic Review
- Managing polycystic ovary syndrome in primary care
- Case 21-2012
- Developing a Framework for Sources of New Product Ideas
- AROMA THERAPY: AN ART OF HEALING
- The beneficial effects of Pumpkin (<i>Cucurbita pepo</i>L.) seed oil for health condition of men
- Exosomes as a novel pathway for regulating development and diseases of the skin (Review)
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Generalized pustular psoriasis responsive to PUVA and oral cyclosporin therapy